Search

everythinglearnresearchcommunity

for

Search:↓

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

Endocannabinoids help control mast cell activity in human skin.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Mast cells might contribute to hair loss by causing skin thickening.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Growth factor treatments are increasingly used in medicine but require more research to fully understand their mechanisms.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Healing of heart and skin wounds in animals are similar.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Ruxolitinib treatment may cause eyelash growth.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Immune cells are crucial for hair growth and preventing hair loss.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document explains various skin conditions and their treatments.